Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study b model 2：Adjusted for the variables in the model 1 plus coronary heart disease, diabetes, hypertension disease, tumor history and lipid lowering agent.
c model 3：Furthered adjusted for the same set of variables in the model 2 plus waist circumference, body mass index, glucose, high-density lipoprotein, total cholesterol, triglyceride and uric acid.
The ORs and 95% CIs were calc ulated by unconditional logistic regression after adjusting for above potential confounders and the cutoff values of bilirubin quartiles for males were direct bilirubin (<3.7, 3.7-4.5, 4.5-5.6, and >=5.6 umol/L), indirect bilirubin (<8.0, 8.0-10.6, 10.6-13.6, and >=13.6 umol/L), and total bilirubin (<12.0, 12.0-15.2, 15.2-19.0, and >=19.0 umol/L) respectively.
The ORs and 95% CIs were calc ulated by unconditional logistic regression after adjusting for above potential confounders and the cutoff values of bilirubin quartiles for females were direct bilirubin (<2.9, 2.9-3.6, 3.6-4.5, and >=4.5 umol/L), indirect bilirubin (<6.6, 6.6-8.6, 8.6-11.2, and >=11.2 umol/L), and total bilirubin (<9.9, 9.9-12.0, 12.0-15.3, and >=15.3 umol/L) respectively.
Supplementary b model 2：Adjusted for the variables in the model 1 plus coronary heart disease, diabetes, hypertension disease, tumor histo ry and lipid lowering agent .
c model 3：Furthered adjusted for the same set of variables in the model 2 plus waist circumference, body mass index, glucose, high-density lipoprotein, total cholesterol, triglyceride and uric acid. b model 2：Adjusted for the variables in the model 1 plus coronary heart disease, diabetes, hypertension disease, tumor histo ry and lipid lowering agent.
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c model 3：Furthered adjusted for the same set of variables in the model 2 plus waist circumference, body mass index, glucose, high-density lipoprotein, total -cholesterol, triglyceride and uric acid.
The ORs and 95% CIs were calc ulated by unconditional logistic regression after adjusting for above potential confounders. The quartiles of bilirubin levels were calculated by sex respectively. The cutoff values of bilirubin quartiles for males were direct bilirubin (<3.7, 3.7-4.5, 4.5-5.6, and >=5.6 umol/L), indirect bilirubin (<8.0, 8.0-10.6, 10.6-13.6, and >=13.6 umol/L), and total bilirubin (<12.0, 12.0-15.2, 15.2-19.0, and >=19.0 umol/L) respectively, and for females were direct bilirubin (<2.9, 2.9-3.6, 3.6-4.5, and >=4.5 umol/L), indirect bilirubin (<6.6, 6.6-8.6, 8.6-11.2, and >=11.2 umol/L), and total bilirubin (<9.9, 9.9-12.0, b model 2：Adjusted for the variables in the model 1 plus coronary heart disease, diabetes, hypertension disease, tumor hist ory and lipid lowering agent.
Supplementary
The ORs and 95% CIs were calc ulated by unconditional logistic regression after adjusting for above potential confounders. The quartiles of bilirubin levels were calculated by sex respectively. The cutoff values of bilirubin quartiles for males were direct bilirubin (<3.7, 3.7-4.5, 4.5-5.6, and >=5.6 umol/L), indirect bilirubin (<8.0, 8.0-10.6, 10.6-13.6, and >=13.6 umol/L), and total bilirubin (<12.0, 12.0-15.2, 15.2-19.0, and >=19.0 umol/L) respectively, and for females were direct bilirubin (<2.9, 2.9-3.6, 3.6-4.5, and >=4.5 umol/L), indirect bilirubin (<6.6, 6.6-8.6, 8.6-11.2, and >=11.2 umol/L), and total bilirubin (<9.9, 9.9-12.0,
